-
If an IRB's policy and procedures manual needs updating, it might be time to write or revamp the section on criteria for review.
-
Sometimes an IRB's caseload grows so big and complex that new processes have to be implemented or the workload is unmanageable.
-
When reviewing cancer clinical trials, IRBs must weigh the risks and benefits to potential participants. But it's not always clear what participants themselves consider to be a risk or a benefit of their enrollment in a study.
-
Research in environmental sciences, engineering and related fields can raise unique ethical issues that may be unfamiliar to many IRBs, particularly when it comes to community-based research.
-
Research institutions occasionally have studies that involve a population or topic that brings up issues of social injustice, such as studies involving war refugee populations or pediatric HIV foster children.
-
Some of the latest versions of electronic health records have created logistical dilemmas for research institutions as they find that providing access to information is more difficult for research monitors, researchers browsing for information about potential subject pools, and other activities.
-
Electronic health records (EHRs) offer a rich resource for facilitating clinical research by identifying patients who fit the eligibility requirements for a study and allowing researchers to collaborate with primary care physicians to recruit them.
-
The Presidential Commission for the Study of Bioethical Issues (PCSBI) has made these 12 recommendations for how to better develop public trust and protect privacy in the era of whole genome sequencing in research:
-
Research institutions should make their complaint process as accessible as possible to researchers, participants, and others, an expert says.
-
More subject diversity is needed in clinical trials to reduce the risk of adverse outcomes, according to the keynote speaker at the Clinical Trials in Georgia conference.